Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M8,428Revenue $M1,289Net Margin (%)14.0Altman Z-Score8.6
Enterprise Value $M7,887EPS $6.3Operating Margin %23.2Piotroski F-Score7
P/E(ttm)53.7Beneish M-Score-3.0Pre-tax Margin (%)22.3Higher ROA y-yN
Price/Book7.710-y EBITDA Growth Rate %--Quick Ratio1.4Cash flow > EarningsY
Price/Sales7.15-y EBITDA Growth Rate %55.8Current Ratio1.5Lower Leverage y-yY
Price/Free Cash Flow27.0y-y EBITDA Growth Rate %-22.7ROA % (ttm)9.4Higher Current Ratio y-yY
Dividend Yield %--PEG1.0ROE % (ttm)15.5Less Shares Outstanding y-yY
Payout Ratio %--Shares Outstanding M46.3ROIC % (ttm)26.1Gross Margin Increase y-yY

Gurus Latest Trades with UTHR

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
UTHRJoel Greenblatt 2015-03-31 Reduce-0.03%$124.93 - $179.51
($152.45)
$ 182.1920%Reduce 9.91%291,077
UTHRFirst Eagle Investment 2015-03-31 Add$124.93 - $179.51
($152.45)
$ 182.1920%Add 3.44%372,580
UTHRKen Fisher 2015-03-31 Buy $124.93 - $179.51
($152.45)
$ 182.1920%New holding2,450
UTHRFirst Eagle Investment 2014-12-31 Add0.03%$122.11 - $134.8
($128.83)
$ 182.1941%Add 37.43%360,180
UTHRJoel Greenblatt 2014-09-30 Reduce-0.4%$86.44 - $136.16
($102.87)
$ 182.1977%Reduce 55.36%288,401
UTHRFirst Eagle Investment 2014-09-30 Buy 0.08%$86.44 - $136.16
($102.87)
$ 182.1977%New holding262,080
UTHRJoel Greenblatt 2014-06-30 Add0.37%$86.14 - $107.81
($96.29)
$ 182.1989%Add 104.14%646,066
UTHRJoel Greenblatt 2014-03-31 Add0.17%$90.67 - $113.39
($102.75)
$ 182.1977%Add 62.64%316,489
UTHRJoel Greenblatt 2013-12-31 Reduce-0.45%$80.03 - $114.51
($89.93)
$ 182.19103%Reduce 47.71%194,595
UTHRVanguard Health Care Fund 2013-09-30 Sold Out -0.32%$66.1 - $79.58
($73.08)
$ 182.19149%Sold Out0
UTHRDavid Dreman 2013-09-30 Sold Out -0.12%$66.1 - $79.58
($73.08)
$ 182.19149%Sold Out0
UTHRJoel Greenblatt 2013-06-30 Add0.13%$59.64 - $69.31
($64.42)
$ 182.19183%Add 15.34%341,330
UTHRJoel Greenblatt 2013-03-31 Add0.02%$51.64 - $62.57
($56.61)
$ 182.19222%Add 2.24%295,921
UTHRVanguard Health Care Fund 2013-03-31 Reduce-0.02%$51.64 - $62.57
($56.61)
$ 182.19222%Reduce 11.23%1,320,000
UTHRDavid Dreman 2013-03-31 Reduce$51.64 - $62.57
($56.61)
$ 182.19222%Reduce 2.46%55,625
UTHRHOTCHKIS & WILEY 2012-12-31 Sold Out -0.09%$44.99 - $58.91
($52.11)
$ 182.19250%Sold Out0
UTHRDavid Dreman 2012-12-31 Buy 0.09%$44.99 - $58.91
($52.11)
$ 182.19250%New holding57,025
UTHRJoel Greenblatt 2012-12-31 Add0.03%$44.992 - $58.91
($52.13)
$ 182.19249%Add 3.34%289,442
UTHRVanguard Health Care Fund 2012-12-31 Reduce-0.03%$44.992 - $58.91
($52.13)
$ 182.19249%Reduce 6.30%1,487,000
UTHRJoel Greenblatt 2012-09-30 Reduce-0.19%$49.87 - $58.3
($54.58)
$ 182.19234%Reduce 15.82%280,089
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

UTHR is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


UTHR: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ROTHBLATT MARTINE AChairman & Co-CEO 2015-06-01Sell2,592$182.66-0.26view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-05-28Sell9,662$180.880.72view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-05-27Sell2,211$184.39-1.19view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-05-26Sell2,592$182.64-0.25view
Thompson Tommy GDirector 2015-05-21Sell1,500$182.040.08view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-05-21Sell9,662$182.44-0.14view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-05-20Sell2,211$182.8-0.33view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-05-18Sell2,592$177.792.47view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-05-14Sell9,662$174.074.66view
ROTHBLATT MARTINE AChairman & Co-CEO 2015-05-13Sell2,211$175.413.87view

Press Releases about UTHR :

    Quarterly/Annual Reports about UTHR:

    News about UTHR:

    Articles On GuruFocus.com
    FDA Approval Of Cancer Drug Catapults United Therapeutics Shares By 2% Mar 11 2015 
    Weekly CFO Sells Highlight: United Therapeutics Corp, Williams Companies Inc, Facebook Inc. Oct 12 2014 
    Here are 5 Good Companies to Consider Investing In Right Now Feb 11 2014 
    High-Dollar Insider Sells - Zuckerberg Sells 41M Facebook Shares Dec 27 2013 
    John Hussman's Third Quarter Top 5 Nov 07 2013 
    Vanguard Health Care Fund Selling Update Oct 30 2013 
    comment on UTHR May 11 2013 
    Super-Fast Growing Mid-Cap Growth Stocks with Explosive Returns May 09 2013 
    5 Fast-Growing Small-Cap Stocks to Watch Mar 26 2013 
    comment on UTHR Mar 23 2013 

    More From Other Websites
    United Therapeutics Corporation - ZER Reports Jun 01 2015
    United Therapeutics Corporation To Present At The Jefferies 2015 Global Healthcare Conference May 29 2015
    United Therapeutics Corporation To Present At The Jefferies 2015 Global Healthcare Conference May 29 2015
    Jim Cramer's Top Takeaways: United Therapeutics, American Airlines, Wix.com May 20 2015
    Jim Cramer's 'Mad Money' Recap: Looking for Profitable Retailers? Follow the Clues May 19 2015
    Cramer Remix: It went to $500 from $5 & isn't done May 19 2015
    Highest paid female CEO: Race to save my daughter May 19 2015
    Live forever? Maybe, by uploading your brain May 04 2015
    LIVE: Sirius founder Martine Rothblatt @ eMerge May 04 2015
    UNITED THERAPEUTICS CORP Financials May 01 2015
    United Therapeutics Corporation To Present At The Deutsche Bank 40th Annual Health Care Conference May 01 2015
    United Therapeutics Corporation To Present At The Deutsche Bank 40th Annual Health Care Conference May 01 2015
    10-Q for United Therapeutics Corp. Apr 30 2015
    UNITED THERAPEUTICS CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in... Apr 30 2015
    [Podcast] Biogen is closing in on the holy grail for biotech stocks Apr 29 2015
    United Therapeutics Falls on Q1 Loss, Misses on Revenues - Analyst Blog Apr 29 2015
    Merck Jumps, United Therapeutics Drops On Q1 Earnings Apr 28 2015
    United Therapeutics' Q1 Sales Miss Hammers Stock Apr 28 2015
    Q1 2015 United Therapeutics Corp Earnings Release - Before Market Open Apr 28 2015
    United Therapeutics reports 1Q loss Apr 28 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK